Tumor revascularization in #glioblatoma is driven by 2 spatially distinct pathways. The GLORIA trial investigated a novel first-line approach for #glioblastoma patients with unfavorable prognostic features: #radiotherapy + #LRNAaptamer targeting #CXCL12 + #bevacizumab
www.nature.com/articles/s41...
0
0
1
0